Company Filing History:
Years Active: 1998-1999
Title: Innovations in Fetal Cell Identification by Mitchell Golbus
Introduction
Mitchell Golbus is an accomplished inventor based in Tiburon, California. He has made significant contributions to the field of prenatal diagnostics through his innovative patents. With a total of two patents to his name, Golbus has focused on the identification of fetal cells from maternal blood samples.
Latest Patents
Golbus's latest patents include the use of anti-embryonic epsilon hemoglobin antibodies to identify fetal cells and the use of anti-embryonic hemoglobin antibodies for the same purpose. These patents describe an in vitro method for identifying or isolating fetal cells from a blood sample. The process involves identifying fetal nucleated erythrocytes or erythroblasts using an antibody or antibody fragment specific for embryonic hemoglobin or an embryonic hemoglobin chain. Once identified, these fetal cells can be treated to make fetal nucleic acids or proteins available for further identification or amplification. This innovative approach allows for quantitative or qualitative diagnostic evaluations, including determining the sex of the fetus and identifying chromosomal or protein abnormalities.
Career Highlights
Golbus is associated with Applied Imaging Corporation, where he continues to advance his research and innovations in the field of prenatal diagnostics. His work has the potential to significantly improve prenatal evaluations and diagnostics, providing critical information to expectant parents and healthcare providers.
Collaborations
[This section has been skipped due to space constraints.]
Conclusion
Mitchell Golbus's contributions to the field of fetal cell identification represent a significant advancement in prenatal diagnostics. His innovative patents pave the way for improved diagnostic methods that can enhance prenatal care and outcomes.